Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results

References

• Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95–111.
   PubMed Web of Science ®Google Scholar
• Burt AD, Alves V, Bedossa P, et al. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2018;73:369–385.
   PubMed Web of Science ®Google Scholar
• Antwi SO, Mousa OY, Patel T. Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995-2014. Ann Hepatol. 2018;17:604–614.
   PubMed Web of Science ®Google Scholar
• Neeff HP, Holzner PA, Menzel M, et al. [Intrahepatic cholangiocarcinoma: Results after 84 resections]. Chirurg. 2018;89:374–380. German.
   PubMed Web of Science ®Google Scholar
• Wright GP, Perkins S, Jones H, et al. Surgical resection does not improve survival in multifocal intrahepatic cholangiocarcinoma: a comparison of surgical resection with intra-arterial therapies. Ann Surg Oncol. 2018;25:83–90.
   PubMed Web of Science ®Google Scholar
• Zhang XF, Beal EW, Bagante F, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105:848–856.
   PubMed Web of Science ®Google Scholar
• Cho SY, Park SJ, Kim SH, et al. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol. 2010;17:1823–1830.
   PubMed Web of Science ®Google Scholar
• Yamashita YI, Shirabe K, Beppu T, et al. Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: a multi-institutional study by the Kyushu Study Group of Liver Surgery. Ann Gastroenterol Surg. 2017;1:136–142.
   PubMed Web of Science ®Google Scholar
• Sommer CM, Kauczor HU, Pereira PL. Locoregional therapies of cholangiocarcinoma. Visc Med. 2016;32:414–420.
   PubMed Web of Science ®Google Scholar
• Xu HX, Wang Y, Lu MD, et al. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol. 2012;85:1078–1084.
   PubMed Web of Science ®Google Scholar
• Butros SR, Shenoy-Bhangle A, Mueller PR, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome. Clin Imaging. 2014;38:490–494.
   PubMed Web of Science ®Google Scholar
• Han Y, Shao N, Xi X, et al. Use of microwave ablation in the treatment of patients with multiple primary malignant tumors. Thorac Cancer. 2017;8:365–371.
   PubMed Web of Science ®Google Scholar
• Medhat E, Abdel AA, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma. J Dig Dis. 2015;16:456–463.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P, Yu XL, et al. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results. Radiology. 2014;270:880–887.
   PubMed Web of Science ®Google Scholar
• Zhang K, Yu J, Yu X, et al. Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma[J]. Int J Hyperthermia. 2018;34(3):1–6.
   PubMed Web of Science ®Google Scholar
• Ren H, Liang P, Yu X, et al. Treatment of liver tumours adjacent to hepatic hilum with percutaneous microwave ablation combined with ethanol injection: a pilot study. Int J Hyperthermia. 2011;27:249–254.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P, Yu XL, et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours. Eur Radiol. 2015;25:1119–1126.
   PubMed Web of Science ®Google Scholar
• Wang J, Liang P, Yu J, et al. Clinical outcome of ultrasound-guided percutaneous microwave ablation on colorectal liver metastases. Oncol Lett. 2014;8:323–326.
   PubMed Web of Science ®Google Scholar
• Hiraoka A, Michitaka K, Kumada T, et al. ALBI score as a novel tool in staging and treatment planning for hepatocellular carcinoma: advantage of ALBI grade for universal assessment of hepatic function. Liver Cancer. 2017;6:377–379.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Yang HI, Sherman M, Su J, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. JCO. 2010;28:2437–2444.
   PubMed Web of Science ®Google Scholar
• Lurje G, Bednarsch J, Roderburg C, et al. Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm. Chirurg, 2018;12:76–82.
   Google Scholar
• Takahashi EA, Kinsman KA, Schmit GD, et al. Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression[J]. Abdom Radio, 2018;4:1–6.
   Google Scholar
• Park HM, Yun SP, Lee EC, et al. Outcomes for patients with recurrent intrahepatic cholangiocarcinoma after surgery. Ann Surg Oncol. 2016;23:4392–4400.
   PubMed Web of Science ®Google Scholar
• Song SC, Heo JS, Choi DW, et al. Survival benefits of surgical resection in recurrent cholangiocarcinoma. J Korean Surg Soc. 2011;81:187–194.
   PubMedGoogle Scholar
• Zhang SJ, Hu P, Wang N, et al. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2013;20:3596–3602.
   PubMed Web of Science ®Google Scholar
• Yantong Y, Shan L, Zhijie C, et al. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy. Eur J Surg Oncol. 2018;44:1595–1602.
   PubMed Web of Science ®Google Scholar
• Chm H, Chiang CL, Fas L, et al. Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT). Oncotarget. 2018;9:28818–28829.
   PubMedGoogle Scholar
• Hou YL, Gao MD, Guo HY, et al. Diagnostic value of albumin-bilirubin grade combined with serum ammonia in cirrhosis with hepatic encephalopathy. Zhonghua Yi Xue Za Zhi. 2018;98:127–131. Chinese.
   PubMedGoogle Scholar
• Ho SY, Liu PH, Hsu CY, et al. Prognostic performance of ten liver function models in patients with hepatocellular carcinoma undergoing radiofrequency ablation. Sci Rep. 2018;8:843.
   PubMed Web of Science ®Google Scholar
• Yu MA, Liang P, Yu XL, et al. Liver abscess as a complication of microwave ablation for liver metastatic cholangiocarcinoma after bilioenteric anastomosis. Int J Hyperthermia. 2011;27:503–509.
   PubMed Web of Science ®Google Scholar